ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

MARTHA MANQUERO-BUTLER M.D.

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,185Medicare Part D Prescriptions Filled, Including Refills

Rank: 389 out of 4623

$659K Total Retail Price of All Prescriptions

Rank: 413 out of 4623

307 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 307 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

21% of this provider’s 307 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 10,412 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LEVOTHYROXINE SODIUM 460 428 1 1
SIMVASTATIN 395 375 2 2
FUROSEMIDE 324 308 3 8
RANITIDINE HCL 291 267 4 47
METOPROLOL TARTRATE 269 265 5 9
OMEPRAZOLE 259 236 6 7
NAMENDA 244 243 7 36
MIRTAZAPINE 222 208 8 57
HYDROCODONE-ACETAMINOPHEN 203 184 S3 9 3
GABAPENTIN 201 175 10 16
TRAMADOL HCL 197 187 11 15
QUETIAPINE FUMARATE 183 168 12 74
SERTRALINE HCL 169 167 13 26
PAROXETINE HCL 167 141 14 78
AMLODIPINE BESYLATE 162 159 15 5
LISINOPRIL 159 153 16 4
POTASSIUM CHLORIDE 155 148 17 14
DONEPEZIL HCL 152 152 18 30
RAMIPRIL 145 131 19 76
LACTULOSE 139 127 20 106
CYMBALTA 138 122 21 48
METFORMIN HCL 133 113 22 6
NOVOLOG 130 117 23 123
TAMSULOSIN HCL 124 112 24 29
CLOPIDOGREL 118 116 25 31
WARFARIN SODIUM 117 110 26 24
HYDROCHLOROTHIAZIDE 115 115 27 10
CARVEDILOL 109 94 28 25
TRAZODONE HCL 107 92 29 42
ZOLPIDEM TARTRATE 105 91 30 18
METOPROLOL SUCCINATE 97 93 31 13
LANTUS 96 92 32 44
PRISTIQ ER 93 92 33 323
LEVEMIR 85 76 34 154
IPRATROPIUM-ALBUTEROL 85 85 34 177
MEGESTROL ACETATE 81 80 R 36 145
METOCLOPRAMIDE HCL 80 79 37 126
PREDNISONE 79 79 38 50
CILOSTAZOL 73 68 39 176
ALENDRONATE SODIUM 72 72 40 22
FAMOTIDINE 71 64 41 82
PLAVIX 71 71 41 45
EXELON 70 70 43 107
PROMETHAZINE HCL 70 69 R 43 93
OLANZAPINE 69 55 45 127
SINGULAIR 68 68 46 83
DIOVAN 66 66 47 39
ESCITALOPRAM OXALATE 66 57 47 75
SEROQUEL 64 57 49 149
SUCRALFATE 59 59 50 183
LOSARTAN POTASSIUM 59 56 50 21
FENTANYL 58 57 S2 52 118
DIGOXIN 58 58 52 58
HYDRALAZINE HCL 56 52 54 99
CARBAMAZEPINE 54 51 55 180
SPIRONOLACTONE 53 53 56 77
CIPROFLOXACIN HCL 52 51 57 43
LYRICA 51 49 58 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.